Farallon Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Farallon Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,552,600	Closed	-$268M	–	119
2015 Q1	$268M	Buy	1,552,600 +1,452,600	+1,453%	+$213M	3.92%	6
2014 Q4	$11.5M	Sell	100,000 -20,000	-17%	-$2.42M	0.16%	66
2014 Q3	$18.7M	Buy	+120,000	New	+$17.4M	0.3%	60

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Farallon Capital Management's SLXP Position: Q2 2015 in Review

Farallon Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,552,600 shares — an estimated $268M sold.

Farallon Capital Management first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $268M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Farallon Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Farallon Capital Management sold 1,552,600 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $268M.
Farallon Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
Farallon Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $268M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Farallon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.